With SpaceX losing altitude and several big IPOs on the docket, investors have much to mull over for the remainder of 2026.

Strategists conclude the IPO wave doesn’t necessarily portend a dangerous market bubble – yet ...

The startup is the first gene editing company to price an IPO in more than two years, though it banked far less than most ...

SpaceX stock shows the Uber IPO warning investors should not ignore: great company, hot IPO demand, Starship risk and a ...

Space Exploration Technologies Corp. SPCX shares are slipping Friday. HSBC launched coverage of the rocket and satellite ...

This company aims to rival AI chip giant Nvidia.

SpaceX has struggled since its debut, and history shows that offerings since 2019 have underperformed in the years since.

These companies are nearing trillion-dollar valuations. However, only one is actually living up to the hype at the moment.

SK Hynix is the latest example of buzzy new offering struggling after its trading debut. ADRs of the Korean chip maker ...

Will SpaceX be more like the big mega-IPO winners of the past or like the big losers?

Attovia Therapeutics is pursuing a U.S. IPO to fund its immune-mediated disease drug pipeline, led by ATTO-1310. Learn more ...